Lemaitre Vascular (LMAT) Tops Q3 EPS by 18c

October 29, 2020 4:47 PM

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.37, $0.18 better than the analyst estimate of $0.19. Revenue for the quarter came in at $36.4 million versus the consensus estimate of $31.62 million.

GUIDANCE:

Lemaitre Vascular sees Q4 2020 EPS of $0.25-$0.35, versus the consensus of $0.22. Lemaitre Vascular sees Q4 2020 revenue of $34-38 million, versus the consensus of $33.46 million.

Lemaitre Vascular sees FY2020 EPS of $0.94-$1.04, versus the consensus of $0.74. Lemaitre Vascular sees FY2020 revenue of $125.8-129.8 million, versus the consensus of $120.47 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

Categories

Earnings Guidance

Next Articles